Quick Answer
Burning Rock Biotech Ltd reported Operating Income of -$357.56 million for fiscal year 2024.
Burning Rock Biotech Ltd Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$357.56M | +46.6% |
| 2023 | -$669.32M | +31.7% |
| 2022 | -$980.41M | -23.0% |
| 2021 | -$797.06M | -93.3% |
| 2020 | -$412.40M | -143.9% |
| 2019 | -$169.09M | -4.8% |
| 2018 | -$161.40M | — |
- Burning Rock Biotech Ltd showed an increase of +46.6% in Operating Income compared to the prior fiscal year.
- Over the 2018–2024 period, Burning Rock Biotech Ltd’s operating income has declined by 121.5% (from -$161.40 million to -$357.56 million).
- The most recent figure is from Burning Rock Biotech Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: